1-167683955-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_052862.4(RCSD1):c.62C>G(p.Ala21Gly) variant causes a missense change. The variant allele was found at a frequency of 0.0000205 in 1,461,828 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_052862.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RCSD1 | NM_052862.4 | c.62C>G | p.Ala21Gly | missense_variant | Exon 2 of 7 | ENST00000367854.8 | NP_443094.3 | |
RCSD1 | NM_001322923.2 | c.62C>G | p.Ala21Gly | missense_variant | Exon 2 of 6 | NP_001309852.1 | ||
RCSD1 | NM_001322924.2 | c.62C>G | p.Ala21Gly | missense_variant | Exon 2 of 5 | NP_001309853.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RCSD1 | ENST00000367854.8 | c.62C>G | p.Ala21Gly | missense_variant | Exon 2 of 7 | 1 | NM_052862.4 | ENSP00000356828.3 | ||
RCSD1 | ENST00000537350.5 | c.62C>G | p.Ala21Gly | missense_variant | Exon 2 of 6 | 1 | ENSP00000439409.1 | |||
RCSD1 | ENST00000361496.3 | c.62C>G | p.Ala21Gly | missense_variant | Exon 2 of 5 | 3 | ENSP00000355291.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251122Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135754
GnomAD4 exome AF: 0.0000205 AC: 30AN: 1461828Hom.: 0 Cov.: 31 AF XY: 0.0000234 AC XY: 17AN XY: 727222
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.62C>G (p.A21G) alteration is located in exon 2 (coding exon 2) of the RCSD1 gene. This alteration results from a C to G substitution at nucleotide position 62, causing the alanine (A) at amino acid position 21 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at